Related Experiment Video
Updated: Dec 14, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
Neonatal hypoglycemia algorithms improve hospital outcomes
Erin A Plummer1, Ivana Ninkovic2, Anna Rees2
1Department of Pediatrics, Division of Neonatology, University of Minnesota, Minneapolis, MN, USA.
Summary
Implementing hypoglycemia algorithms (HGA) streamlined care for at-risk newborns, reducing intravenous dextrose use and NICU admissions. The updated HGA, including dextrose gel, maintained benefits and cut costs, improving infant outcomes.
Area of Science:
- Neonatal Medicine
- Pediatrics
- Healthcare Management
Background:
- Neonatal hypoglycemia management protocols vary, impacting infant care and hospital resources.
- Standardized hypoglycemia algorithms (HGA) can streamline treatment for at-risk newborns.
Purpose of the Study:
- To implement and evaluate the impact of hypoglycemia algorithms (HGA) on neonatal hypoglycemia management.
- To improve outcomes for the mother-infant dyad and reduce hospital costs associated with neonatal hypoglycemia.
Main Methods:
- Retrospective cohort study of 4,666 asymptomatic infants at risk for hypoglycemia (2010-2016).
- Analysis of outcomes across three epochs: pre-HGA (2010-2011), HGA1 (2012-2013), and HGA2 (2014-2016, including dextrose gel).
- Cost savings calculated using linear regression.
Main Results:
- HGA implementation reduced intravenous dextrose use compared to the pre-HGA period (3.9% to 2.5% and 1.0%).
- The HGA2 group showed increased breastfeeding rates (86.7% to 88.4%) and decreased NICU admissions (10.6% to 9.4%).
- Total cost savings approximated $222 per case, with no change in length of stay.
Conclusions:
- Hypoglycemia algorithms (HGA) effectively improved short-term outcomes for asymptomatic infants at risk.
- Updating HGA to include dextrose gel maintained benefits and further enhanced outcomes, reducing overall care costs.
- Standardized HGA positively impacts neonatal care, promoting mother-infant bonding and cost-efficiency.
Related Concept Videos
01:15Hypoglycemia and Glucagon
679
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
679
01:14SBAR II: Application of SBAR
5.5K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
5.5K
01:20Pathophysiology of Diabetes
2.9K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
01:22Diabetes Mellitus: Type 2 and Gestational
4.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
01:02Glucose Homeostasis: Regulation of Blood Glucose
3.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.5K
01:06Oral Hypoglycemic Agents: Glinides
480
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
480